Open AccessP341: A NOVEL BISPECIFIC T CELL ENGAGER (UMG2‐CD3) IS EFFECTIVE AGAINST CORTICAL‐DERIVED ACUTE LYMPHOBLASTIC LEUKEMIA
Author(s) -
Riillo C.,
Caracciolo D.,
Grillone K.,
Polerà N.,
Tuccillo F. M.,
Bonelli P.,
Juli G.,
Ascrizzi S.,
Scionti F.,
Arbitrio M.,
Lopreiato M.,
Siciliano M. A.,
Sestito S.,
Talarico G.,
Galea E.,
Galati M. C.,
Rossi M.,
Ballerini A.,
Gentile M.,
Di Martino M. T.,
Tagliaferri P.,
Tassone P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844252.94608.e6
Subject(s) - t cell , epitope , flow cytometry , blinatumomab , cancer research , antigen , immunotherapy , leukemia , antibody , monoclonal antibody , medicine , immune system , immunology , microbiology and biotechnology , biology , cd19